Literature DB >> 18457825

Effects of harman and norharman on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells.

Yoo Jung Yang1, Jae Joon Lee, Chun Mei Jin, Sung Cil Lim, Myung Koo Lee.   

Abstract

The effects of harman and norharman on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells were investigated. Harman and norharman at a concentration of 20 microM and 100 microM showed 49.4% and 49.5% inhibition of dopamine content for 48 h, respectively. The IC50 values of harman and norharman were 21.2 microM and 103.3 microM. Dopamine content, tyrosine hydroxylase (TH) activity and TH mRNA levels were decreased during the first 6 h, maintained for up to 48 h and then gradually recovered at 72 h after exposure to 20 microM harman and 100 microM norharman. Under the same conditions, the intracellular cyclic AMP levels and Ca2+ concentrations were also decreased by harman and norharman. In addition, harman and norharman at concentrations higher than 80 microM and 150 microM caused cytotoxicity at 48 h in PC12 cells. Non-cytotoxic ranges of 10-30 microM harman and 50-150 microM norharman inhibited L-DOPA (20-50 microM)-induced increases in dopamine content at 48 h. Harman at 20-150 microM and norharman at 100-300 microM also enhanced L-DOPA (20-100 microM)-induced cytotoxicity at 48 h with an apoptotic process. These results suggest that harman and norharman inhibit dopamine biosynthesis by reducing TH activity and enhance L-DOPA-induced cytotoxicity in PC12 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18457825     DOI: 10.1016/j.ejphar.2008.03.050

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Harmine treatment enhances short-term memory in old rats: Dissociation of cognition and the ability to perform the procedural requirements of maze testing.

Authors:  Sarah E Mennenga; Julia E Gerson; Travis Dunckley; Heather A Bimonte-Nelson
Journal:  Physiol Behav       Date:  2014-09-22

2.  Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.

Authors:  David J Wagner; Haichuan Duan; Alenka Chapron; Richard W Lee; Joanne Wang
Journal:  Xenobiotica       Date:  2017-03-02       Impact factor: 1.908

3.  A beta-carboline alkaloid from the Papua New Guinea marine sponge hyrtios reticulatus.

Authors:  Wayne D Inman; Walter M Bray; Nadine C Gassner; R Scott Lokey; Karen Tenney; Young Yongchun Shen; Karen Tendyke; Ted Suh; Phillip Crews
Journal:  J Nat Prod       Date:  2010-02-26       Impact factor: 4.050

4.  Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in Parkinson's disease.

Authors:  Elan D Louis; Monika Michalec; Wendy Jiang; Pam Factor-Litvak; Wei Zheng
Journal:  Neurotoxicology       Date:  2013-12-01       Impact factor: 4.294

5.  β-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites.

Authors:  Danielle Frost; Bessie Meechoovet; Tong Wang; Stephen Gately; Marco Giorgetti; Irina Shcherbakova; Travis Dunckley
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

Review 6.  Structures and Biological Activities of Alkaloids Produced by Mushrooms, a Fungal Subgroup.

Authors:  Jesús G Zorrilla; Antonio Evidente
Journal:  Biomolecules       Date:  2022-07-24

Review 7.  Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases.

Authors:  P R Bharadwaj; K A Bates; T Porter; E Teimouri; G Perry; J W Steele; S Gandy; D Groth; R N Martins; Giuseppe Verdile
Journal:  Transl Psychiatry       Date:  2013-12-03       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.